(2020). Defining tumo r resistance to OSE2101 Protocol OSE2101C301 Confidential Version n°6.0 Page 84 of 101 02 February 2022 PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce. J.